Shanghai, China

Shiqi Han


 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2022-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Shiqi Han: Innovating in the Field of Pharmaceutical Research

Introduction

Shiqi Han, a talented inventor based in Shanghai, CN, has made significant contributions to the field of pharmaceutical research. With a keen focus on developing novel compounds to target specific mutations, Han has gained recognition for his innovative approach to drug discovery.

Latest Patents

Han's latest patents showcase his expertise in developing compounds that act as KRAS G12C mutein inhibitors. These patents revolve around a class of pyridone-pyrimidine derivatives represented by formula (I), and their pharmaceutically acceptable salts. By targeting the KRAS G12C mutation, these inhibitors hold great promise in the treatment of certain types of cancer.

Career Highlights

Shiqi Han is affiliated with Medshine Discovery Inc., a prominent company at the forefront of pharmaceutical research and drug development. Within this innovative environment, Han has been able to nurture his ideas and bring them to fruition, resulting in valuable patents that contribute to the company's success.

Collaborations

In his professional journey, Han has collaborated with esteemed coworkers such as Yaxian Cai and Zhaobing Xu. This collaborative effort has not only enriched his own work but has also fostered a culture of innovation and exchange of ideas within the research team.

Conclusion

In conclusion, Shiqi Han exemplifies the spirit of innovation in the field of pharmaceutical research. His dedication to developing novel compounds and his collaboration with talented coworkers have yielded patents that have the potential to make a significant impact in the realm of cancer treatment. Han's contributions underscore the importance of inventive thinking and collaboration in driving advancements in the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…